Navigation Links
Swype Cold & Flu Shield Significantly Reduces Occurrence of Colds in Clinical Study
Date:9/27/2011

PONTE VEDRA BEACH, Fla., Sept. 27, 2011 /PRNewswire/ -- Nuance Health today announced the results of an eight-week clinical study that was conducted on their innovative product, Swype Cold & Flu Shield, during the 2010-11 cold and flu season.  

The clinical study, conducted on 103 volunteers who identified themselves as typically susceptible to colds, evaluated the effectiveness, tolerability, and willingness of participants to use a nasal gel to prevent illness.  In previous testing performed by an independent microbiology laboratory, the active ingredients in Swype have been shown to kill over 99.9% of all 25 cold and flu viruses tested including 15 serotypes of rhinovirus and swine influenza (H1N1).  In the study, participants were instructed to use Swype three times daily for eight weeks during the cold and flu season.  The volunteers reported actual use of the product and cold symptoms via weekly email surveys.

The results of the clinical study were outstanding.  Over 83% of volunteers used Swype two or three times per day during the study, an excellent compliance rate for a prophylactic product (fewer people wash their hands after using the bathroom).  In a typical cold and flu season, about 45% of participants would have experienced moderate or stronger cold symptoms during an eight-week period, but only 2% of Swype users reported more than mild cold symptoms.  Overall, users of Swype experienced about 70% fewer colds than anticipated, an unprecedented result for a cold prevention product.

Volunteers in the study offered unprompted praise for Swype Cold & Flu Shield: "I love Swype and tell many about your product," "Overall the product is invisible, light, and easy to use," "Everyone around me is sick, but not me," and "I actually had a cold when I started using Swype and within one day it was gone" are examples of comments posted by Swype users.

"I am very excited about the results of
'/>"/>

SOURCE Nuance Health
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nuance Health Introduces Swype, an Innovative New Product Designed to Enhance Defense Against Colds and Flu
2. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
3. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
4. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
5. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
6. Robbins & Myers Announces Regular Quarterly Cash Dividend
7. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
8. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
9. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
10. Robbins & Myers Announces Fourth Quarter and Full Year 2009 Results
11. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... marzo 2015  SI-BONE, Inc., una società per ... fusione con chirurgia mininvasiva (minimally invasive surgical/MIS) per ... System ® , ha annunciato oggi che oltre ... intero utilizzando oltre 44.000 iFuse Implants.  ... adottata guadagnando consenso con oltre 900 chirurghi che ...
(Date:3/2/2015)... March 2, 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ... $15 million milestone payment from GSK related to advancing the ... familial amyloid polyneuropathy (FAP).  "We are very ... , and plan to report data from the Phase 2/3 ... fifteen months of dosing and are now receiving ISIS-TTR Rx ...
(Date:3/2/2015)... 2, 2015   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... developing breakthrough treatments for human disease, will release its ... Wednesday, March 4, 2015 before the financial markets open.  ... to discuss clinical development progress and financial results for ... 10:00 a.m. Eastern Time on March 4, 2015. ...
Breaking Medicine Technology:SI-BONE, Inc. rivela l'obiettivo di 15.000 interventi con iFuse 2SI-BONE, Inc. rivela l'obiettivo di 15.000 interventi con iFuse 3SI-BONE, Inc. rivela l'obiettivo di 15.000 interventi con iFuse 4Isis Pharmaceuticals Earns $15 Million From GSK for Advancing ISIS-TTR Rx 2Isis Pharmaceuticals Earns $15 Million From GSK for Advancing ISIS-TTR Rx 3Lexicon To Report Fourth Quarter And Year End 2014 Financial Results On March 4, 2015 2
... MORRISVILLE, N.C., Sept. 11 Clinical Logistics is pleased to announce ... Corporation (Gentris), a GLP compliant laboratory, located in Morrisville, North Carolina. ... DNA, RNA, whole blood, FFPE tissue blocks, urine, plasma, serum, saliva, ... storage conditions is available: , , ...
... YORK, Sept. 11 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova ... method for destroying breast cancer cells, using stem cell ... that enables us to identify the protein expression in ... tumors. This ability to identify the molecular markers of ...
Cached Medicine Technology:Clinical Logistics Enters Partnership with Gentris Corporation 2New stem cell identification technology could cure breast cancer 2
(Date:3/2/2015)... 2015 Representatives with BNatrl ( ... launched a multivitamin supplement that’s specifically designed for ... for BNatrl, said the multivitamin, which launched Jan. ... other world-class athletes. , "Being an avid marathon ... whole food multivitamin to improve my performance,” said ...
(Date:3/2/2015)... Atlantic Information Services, Inc. (AIS) is pleased to ... Plans: 2015 , the all-new 12th edition of the ... market, with enrollment data and contact information for health ... as a printed book containing the full directory and ... and charts, as well as an electronic version, AIS’s ...
(Date:3/2/2015)... TX (PRWEB) March 02, 2015 What ... How should physicians request references? When are interviews scheduled, ... analyze employment opportunities?, Both training and practicing physicians who ... to these questions and more at the PracticeLink Physician ... 18. The drop-in Job Fair is from 5:30 to ...
(Date:3/2/2015)... Final Cut Pro X plugin specialists have ... Film Studios. , “The TranStatic Volume 2 plugin gives users ... CEO of Pixel Film Studios. “TranStatic Volume 2 is a ... editors toolbox.” , With TranStatic Volume 2 users can transition ... scrambling effects from Pixel Film Studios. Users have total control ...
(Date:3/1/2015)... Excellence is pleased to announce the addition of a digital ... are over 75 terms and phrases available for viewing, with more ... patients a better understanding of what our Providers are talking about ... With this resource, our patients are able to go back to ... that they may not remember or comprehend at the time of ...
Breaking Medicine News(10 mins):Health News:Bnatrl Launches Multivitamin Supplement for Runners 2Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2
... of brain tumor , , MONDAY, June 2 (HealthDay News) -- ... malignant brain tumor that was diagnosed last month. , The ... an especially lethal type of brain tumor, at Duke University ... Massachusetts Democrat,s office said he would be operated on by ...
... in 81 years the International Congress of Genetics takes place ... Nobel Prize winners get together with more than 2000 scientists ... genome analysis. The congress, which takes place for the 20th ... also being Berlin. Congress Chairman is Prof. Rudi Balling, Scientific ...
... PETERSBURG, Fla., June 2 The Advanced,Wound Management Division ... that its negative pressure wound therapy (NPWT) products will ... included in the,first phase of the competitive bidding program ... in the U.S. The program, which is,scheduled to take ...
... completed ... phase I studies, SAN ... of a worldwide exclusive agreement entered into in Feb,2008, GlaxoSmithKline (GSK) ... original agreement, GSK has rights to develop,manufacture and commercialize FLAP (5-Lipoxygenase ...
... Imagine being able to communicate,your practice,s message to ... practice growth and development. That is the focus of ... parent company of JG Pads, a pharmaceutical sales,support company ... United States since 1993. Because of its success, MarketHATCH ...
... Scientists at the University of Liverpool have found that ... antibiotics, suggesting that the infection is unlike the bacteria ... resistant to antibiotics and can sometimes go undetected in ... spread to humans. The team tested the strains found ...
Cached Medicine News:Health News:Sen. Kennedy Undergoing Surgery for Brain Tumor 2Health News:Sen. Kennedy Undergoing Surgery for Brain Tumor 3Health News:Sen. Kennedy Undergoing Surgery for Brain Tumor 4Health News:6 Nobel Prize Winners at International Congress of Genetics 2Health News:6 Nobel Prize Winners at International Congress of Genetics 3Health News:Smith & Nephew Negative Pressure Wound Therapy Products To Be Available To Patients Through the Medicare Part B Competitive Bidding Process 2Health News:Smith & Nephew Negative Pressure Wound Therapy Products To Be Available To Patients Through the Medicare Part B Competitive Bidding Process 3Health News:Smith & Nephew Negative Pressure Wound Therapy Products To Be Available To Patients Through the Medicare Part B Competitive Bidding Process 4Health News:Smith & Nephew Negative Pressure Wound Therapy Products To Be Available To Patients Through the Medicare Part B Competitive Bidding Process 5Health News:Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline 2Health News:Ohio Company to Debut Turnkey Marketing Material During Florida National Dental Convention 2Health News:Salmonella in garden birds responsive to antibiotics 2
Take Performance to a Higher Level....
The MULTI-LINK PIXEL Coronary Stent System was designed to address the challenges of small vessel treatment in patients with abrupt or threatened abrupt closure (ATC)....
FemoStop plus system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic ...
... used to seal the arterial puncture site. Duett ... the arteriotomy and the tissue tract with a ... a balloon catheter and procoagulant - the Duett ... stop the bleeding. The Duett is unique in ...
Medicine Products: